Suppr超能文献

一种用于定量调节性T细胞介导的对CD4 T细胞抑制作用的新颖且快速的方法。

A novel and rapid method to quantify Treg mediated suppression of CD4 T cells.

作者信息

Long Anna E, Tatum Megan, Mikacenic Carmen, Buckner Jane H

机构信息

Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.

Department of Medicine, University of Washington, Seattle, WA, USA.

出版信息

J Immunol Methods. 2017 Oct;449:15-22. doi: 10.1016/j.jim.2017.06.009. Epub 2017 Jun 22.

Abstract

Measuring regulatory T cell suppression provides important insight into T cell dysfunction in autoimmune disease. However, to date, suppression assays are limited by the requirement for freshly isolated cells, and significant cell numbers. Here, we present a novel and rapid in vitro assay using effector T cell surface expression of both CD25 and CD134 as a surrogate marker of regulatory T cell-mediated suppression. This surface marker-based suppression assay works for frozen samples and for samples with limited cell numbers. It is also shorter taking two days to complete compared to the four days required for proliferation-based assays. Furthermore, this assay works with both in vitro expanded and natural Tregs, as well as anti-CD3/anti-CD28 bead-based and APC stimulation conditions. In conclusion, we have developed and validated a new suppression assay for cryopreserved samples with limited cell numbers that may be helpful to investigate T cell regulation in the context of infection or autoimmune diseases.

摘要

测量调节性T细胞抑制作用可为深入了解自身免疫性疾病中的T细胞功能障碍提供重要线索。然而,迄今为止,抑制试验受到新鲜分离细胞的需求以及大量细胞数量的限制。在此,我们提出了一种新型快速体外试验,利用效应T细胞表面表达的CD25和CD134作为调节性T细胞介导抑制作用的替代标志物。这种基于表面标志物的抑制试验适用于冷冻样本和细胞数量有限的样本。与基于增殖的试验所需的四天相比,它完成时间更短,只需两天。此外,该试验适用于体外扩增的天然调节性T细胞,以及基于抗CD3/抗CD28磁珠和抗原呈递细胞刺激的条件。总之,我们已经开发并验证了一种针对细胞数量有限的冷冻样本的新型抑制试验,这可能有助于在感染或自身免疫性疾病背景下研究T细胞调节。

相似文献

1
A novel and rapid method to quantify Treg mediated suppression of CD4 T cells.
J Immunol Methods. 2017 Oct;449:15-22. doi: 10.1016/j.jim.2017.06.009. Epub 2017 Jun 22.
3
Feedback loop of immune regulation by CD4+CD25+ Treg.
Immunobiology. 2009;214(4):291-302. doi: 10.1016/j.imbio.2008.09.004. Epub 2008 Nov 1.
4
IL-10 is required for human CD4(+)CD25(+) regulatory T cell-mediated suppression of xenogeneic proliferation.
Immunol Cell Biol. 2010 May-Jun;88(4):477-85. doi: 10.1038/icb.2009.117. Epub 2010 Feb 23.
7
A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
J Immunol Methods. 2012 Jan 31;375(1-2):148-58. doi: 10.1016/j.jim.2011.10.004. Epub 2011 Oct 12.
8
Lenalidomide potentiates CD4CD25Treg-related suppression of lymphoma B-cell proliferation.
Clin Exp Med. 2017 May;17(2):193-207. doi: 10.1007/s10238-016-0411-8. Epub 2016 Mar 10.
9
A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
J Immunol Methods. 2007 Apr 30;322(1-2):1-11. doi: 10.1016/j.jim.2007.01.025. Epub 2007 Mar 5.

引用本文的文献

1
Assessing Human Treg Suppression at Single-Cell Resolution Using Mass Cytometry.
Bio Protoc. 2025 Aug 20;15(16):e5424. doi: 10.21769/BioProtoc.5424.
2
Single cell suppression profiling of human regulatory T cells.
Nat Commun. 2025 Feb 3;16(1):1325. doi: 10.1038/s41467-024-55746-1.
3
Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesis.
J Exp Med. 2023 Mar 6;220(3). doi: 10.1084/jem.20221676. Epub 2023 Jan 4.
4
IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function.
JCI Insight. 2022 Nov 22;7(22):e159436. doi: 10.1172/jci.insight.159436.
5
Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint.
Clin Transl Immunology. 2022 Sep 30;11(10):e1420. doi: 10.1002/cti2.1420. eCollection 2022.
6
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.
JCI Insight. 2021 Nov 8;6(21):e150074. doi: 10.1172/jci.insight.150074.
7
Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes.
Diabetologia. 2022 Feb;65(2):343-355. doi: 10.1007/s00125-021-05595-0. Epub 2021 Oct 28.
8
and CD8 T Cell Suppression Assays.
Bio Protoc. 2021 May 20;11(10):e4020. doi: 10.21769/BioProtoc.4020.
10
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances.
Diabetes. 2019 Jul;68(7):1366-1379. doi: 10.2337/db19-0119.

本文引用的文献

4
Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease.
Transfusion. 2014 Feb;54(2):353-63. doi: 10.1111/trf.12279. Epub 2013 Jun 17.
7
A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy.
Blood. 2012 Feb 23;119(8):e57-66. doi: 10.1182/blood-2011-09-380048. Epub 2012 Jan 4.
8
Suppression assays with human T regulatory cells: a technical guide.
Eur J Immunol. 2012 Jan;42(1):27-34. doi: 10.1002/eji.201141651. Epub 2011 Dec 12.
9
A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
J Immunol Methods. 2012 Jan 31;375(1-2):148-58. doi: 10.1016/j.jim.2011.10.004. Epub 2011 Oct 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验